Status:
COMPLETED
Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
University of California, Irvine
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of med...
Eligibility Criteria
Inclusion
- Fluent in English
- Aged between 18-35 years old
- Agree to provide blood samples
- Healthy adults who weigh at least 110 pounds
- Agree to devote 40 minutes daily to this study for a week
Exclusion
- Have a disorder that would affect heart rhythm or function (e.g., abnormal cardiac rhythm, dyspnea, heart disease including coronary artery disease, angina and arrhythmia)
- Regularly practicing any relaxation, meditation or yoga that involve breathing focused practices lasting for more than an hour each week
Key Trial Info
Start Date :
January 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06210035
Start Date
January 29 2024
End Date
May 3 2024
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90089